Jialu Xu
- Immunology top 5%
- Immunotherapy and Immune Responses 11
- Immune cells in cancer 8
- Immune Cell Function and Interaction 4
- Cancer Research top 10%
- Biomaterials top 5%
- Biomedical Engineering top 5%
- Nanoplatforms for cancer theranostics 12
- Molecular Biology top 10%
- Extracellular vesicles in disease 13
-
- Neuroinflammation and Neurodegeneration Mechanisms 4
-
- CAR-T cell therapy research 4
- Cancer Immunotherapy and Biomarkers 4
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Jialu Xu
51 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 108
- Immunology 461
- Cancer Research 228
- Biomaterials 193
- Biomedical Engineering 608
- Molecular Biology 782
Countries citing papers authored by Jialu Xu
This map shows the geographic impact of Jialu Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jialu Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jialu Xu more than expected).
Fields of papers citing papers by Jialu Xu
This network shows the impact of papers produced by Jialu Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jialu Xu. The network helps show where Jialu Xu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jialu Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 3 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 1 | |
| 5 | 2025 | 2 | |
| 6 | 2025 | 0 | |
| 7 | 2025 | 0 | |
| 8 | 2025 | 0 | |
| 9 | 2024 | 12 | |
| 10 | 2024 | 1 | |
| 11 | 2024 | 32 | |
| 12 | 2023 | 13 | |
| 13 | 2023 | 3 | |
| 14 | 2023 | 20 | |
| 15 | 2023 | 1 | |
| 16 | 2023 | 81 | |
| 17 | 2022 | 90 | |
| 18 | 2021 | 42 | |
| 19 | 2020 | 78 | |
| 20 | 2020 | 150 |
About Jialu Xu
Jialu Xu is a scholar working on Immunology, Neurology and Microbiology, having authored 56 papers that have together received 1.7k indexed citations. Recurring topics across this work include Extracellular vesicles in disease (13 papers), Nanoplatforms for cancer theranostics (12 papers), Immunotherapy and Immune Responses (11 papers), Immune cells in cancer (8 papers), Neuroinflammation and Neurodegeneration Mechanisms (4 papers), CAR-T cell therapy research (4 papers), Immune Cell Function and Interaction (4 papers) and Cancer Immunotherapy and Biomarkers (4 papers). The work is most often cited by research in Immunology (461 citations), Cancer Research (228 citations) and Biomaterials (193 citations). Jialu Xu has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Chao Wang, Qingle Ma, Qin Fan, Huaxing Dai, Yue Zhang, Ziying Fei, Ziliang Dong, Jinyu Bai, Zhuang Liu and Qianyu Yang. Their work appears in journals such as Frontiers in Immunology, Advanced Materials, Science Advances, ACS Biomaterials Science & Engineering and Cell Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.